Helix BioPharma

Contact
helixbiopharma.com
+1905841-2300233

Helix BioPharma Corp.

305 Industrial Parkway South, Unit 3
L4G 6X7 Aurora
Canada
+1905841-2300233
helixbiopharma.com
Contact
Profile Products News
Contact

About Helix BioPharma

Read more about Helix BioPharma
Facts about Helix BioPharma
  • Industry : Pharma

Product portfolio of Helix BioPharma

Product portfolio

Show all

News about Helix BioPharma

Helix BioPharma

09-Nov-2009 | research and development

Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b

Helix BioPharma Corp. announced that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient ...

Read news
Helix BioPharma

19-Aug-2009 | people

Helix BioPharma Announces the Appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its Board of Directors

Helix BioPharma Corp. announced the appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its board of directors. Professor Roszkowski-Sliz is ...

Read news
Helix BioPharma

18-Mar-2009 | research and development

Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b

Helix BioPharma Corp. announced that it has received the necessary regulatory approvals in Germany to initiate its planned Phase II pharmacokinetic study ...

Read news
Helix BioPharma

18-Sep-2007 | research and development

Helix BioPharma awarded U.S. Patent for DOS47 adjunct chemotherapy applications

Helix BioPharma Corp. announced the issuance of its second DOS47 patent (U.S. Patent No. 7,264,800) from the United States Patent & Trademark Office, ...

Read news
Helix BioPharma

07-May-2007 | research and development

Helix BioPharma awarded first U.S. Patent for DOS47

Helix BioPharma Corp. announced the issuance of a patent (U.S. Patent No. 7,211,250) from the United States Patent & Trademark Office relating to the ...

Read news
Helix BioPharma

04-Apr-2007 | research and development

Helix BioPharma Corp. announces positive phase II clinical results with its Topical Interferon Alpha-2b

Helix announced positive results from its phase II clinical study of its Topical Interferon Alpha-2b in women with human papilloma virus (HPV) induced low- ...

Read news
Helix BioPharma

09-Jan-2007 | business & finance

Helix BioPharma Corp. signs L-DOS47 manufacturing agreement with BioVectra dcl

Helix BioPharma Corp. announced that it has signed an agreement with BioVectra, a division of Diagnostic Chemicals Limited ("BioVectra dcl"), to ...

Read news
Helix BioPharma

15-Sep-2005 | research and development

Helix receives approval to conduct a clinical trial of Topical Interferon Alpha-2b in Sweden

Helix BioPharma announced that it has received approval from Sweden's drug regulatory authority, the Medical Products Agency (MPA), to conduct a Phase II ...

Read news
Show more news about Helix BioPharma

Here you will find Helix BioPharma Corp.